Amorphous Form Stability
Amorphous Form Stability is a pharmaceutical stability construct that characterizes the resistance of a drug substance in its non-crystalline solid state to physicochemical degradation and structural changes over time under defined environmental conditions.
872
Publications
46.4K
Citations
2.9K
Authors
816
Institutions
Publications per year
2017–2026
308
Parents
872
Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals
N.J. Babu, Ashwini Nangia · Crystal Growth & Design · 2011 · 986 citations
Pharmacy, Chemistry, Pharmacology +17
1–5 of 872
2.9K
36
h-index
27
h-index
25
h-index
19
h-index
18
h-index
1–5 of 2.9K
816
University of Copenhagen
Copenhagen, Denmark
34 h-index
210 publications
10.5K citations
Purdue University West Lafayette
West Lafayette, United States
25 h-index
67 publications
6.2K citations

Centre National de la Recherche Scientifique
Paris, France
22 h-index
67 publications
3.3K citations
University of Wisconsin–Madison
Madison, United States
22 h-index
67 publications
6.8K citations

University of Otago
Dunedin, New Zealand
21 h-index
72 publications
5.5K citations
Institute of Physics
Warsaw, Poland
20 h-index
110 publications
4.7K citations

University of Silesia in Katowice
Katowice, Poland
20 h-index
117 publications
4.9K citations
University of Connecticut
Storrs, United States
18 h-index
49 publications
3.5K citations
1–8 of 816
75 publications · 6.5K citations
42
h-index
94 publications · 4.4K citations
40
h-index
47 publications · 5.6K citations
36
h-index
60 publications · 3.3K citations
36
h-index
EJPB · 42 publications · 2.2K citations
30
h-index
1–5